Thrombin regulates the ability of Schwann cells to support neuritogenesis and to maintain the integrity of the nodes of Ranvier.


Journal

European journal of histochemistry : EJH
ISSN: 2038-8306
Titre abrégé: Eur J Histochem
Pays: Italy
ID NLM: 9207930

Informations de publication

Date de publication:
30 Mar 2020
Historique:
received: 09 01 2020
accepted: 13 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 11 11 2020
Statut: epublish

Résumé

Schwann cells (SC) are characterized by a remarkable plasticity that enables them to promptly respond to nerve injury promoting axonal regeneration. In peripheral nerves after damage SC convert to a repair-promoting phenotype activating a sequence of supportive functions that drive myelin clearance, prevent neuronal death, and help axon growth and guidance. Regeneration of peripheral nerves after damage correlates inversely with thrombin levels. Thrombin is not only the key regulator of the coagulation cascade but also a protease with hormone-like activities that affects various cells of the central and peripheral nervous system mainly through the protease-activated receptor 1 (PAR1). Aim of the present study was to investigate if and how thrombin could affect the axon supportive functions of SC. In particular, our results show that the activation of PAR1 in rat SC cultures with low levels of thrombin or PAR1 agonist peptides induces the release of molecules, which favor neuronal survival and neurite elongation. Conversely, the stimulation of SC with high levels of thrombin or PAR1 agonist peptides drives an opposite effect inducing SC to release factors that inhibit the extension of neurites. Moreover, high levels of thrombin administered to sciatic nerve ex vivo explants induce a dramatic change in SC morphology causing disappearance of the Cajal bands, enlargement of the Schmidt-Lanterman incisures and calcium-mediated demyelination of the paranodes. Our results indicate thrombin as a novel modulator of SC plasticity potentially able to favor or inhibit SC pro-regenerative properties according to its level at the site of lesion.

Identifiants

pubmed: 32236088
doi: 10.4081/ejh.2020.3109
pmc: PMC7132140
doi:

Substances chimiques

N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine 0
Pyrroles 0
Quinazolines 0
Receptor, PAR-1 0
Thapsigargin 67526-95-8
Thrombin EC 3.4.21.5
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Proc Natl Acad Sci U S A. 1990 Jun;87(11):4212-6
pubmed: 2349231
J Thromb Haemost. 2005 Aug;3(8):1800-14
pubmed: 16102047
Neuroscience. 2016 Dec 17;339:587-598
pubmed: 27771530
Cell Rep. 2016 Jul 12;16(2):314-322
pubmed: 27346352
Ann Otol Rhinol Laryngol. 1998 Jan;107(1):61-9
pubmed: 9439391
Dev Neurobiol. 2014 Jul;74(7):676-91
pubmed: 24403178
Br J Pharmacol. 2014 Mar;171(5):1180-94
pubmed: 24354792
Mol Biosyst. 2015 Jun;11(6):1584-93
pubmed: 25728364
Mol Pharmacol. 2016 May;89(5):606-14
pubmed: 26957205
Nature. 2006 Feb 23;439(7079):988-92
pubmed: 16372019
J Neural Transm (Vienna). 2019 Oct;126(10):1259-1271
pubmed: 31493095
Brain. 2008 Apr;131(Pt 4):1113-22
pubmed: 18299297
Exp Neurol. 1999 Feb;155(2):252-9
pubmed: 10072300
Ann Surg. 1980 Dec;192(6):738-42
pubmed: 7447527
Pharmacol Rev. 2001 Jun;53(2):245-82
pubmed: 11356985
PLoS One. 2013;8(2):e56484
pubmed: 23409189
Mol Cell Neurosci. 2017 Mar;79:23-33
pubmed: 28064059
Glia. 1997 Aug;20(4):333-47
pubmed: 9262237
Scand J Surg. 2011;100(3):223-9
pubmed: 22108753
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2264-9
pubmed: 10681455
PLoS One. 2019 Jul 5;14(7):e0219453
pubmed: 31276565
Nature. 2004 Sep 9;431(7005):191-5
pubmed: 15356632
Biochem Soc Trans. 2011 Jun;39(3):789-97
pubmed: 21599650
J Neurobiol. 2005 Apr;63(1):29-48
pubmed: 15702477
Nature. 2016 Jan 28;529(7587):523-7
pubmed: 26760212
Glia. 2015 May;63(5):846-59
pubmed: 25628003
Glia. 2013 Sep;61(9):1456-70
pubmed: 23832758
Int J Cardiol. 2018 Feb 1;252:167-168
pubmed: 29249426
Neuroscience. 2016 Apr 21;320:93-104
pubmed: 26851772
Bull Exp Biol Med. 2005 Jan;139(1):4-6
pubmed: 16142261
Neuroscience. 2018 Feb 10;371:445-454
pubmed: 29292076
J Neurosci Res. 1997 Oct 15;50(2):291-9
pubmed: 9373038
Front Cell Neurosci. 2019 Feb 11;13:33
pubmed: 30804758
Muscle Nerve. 2012 Feb;45(2):231-41
pubmed: 22246880
Stroke. 2014 Mar;45(3):896-9
pubmed: 24473182
Front Neurol. 2019 Jan 04;9:1139
pubmed: 30662428

Auteurs

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH